- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05394441
Health and Quality of Life of ITMO University's Students, Faculty and Staff
March 4, 2024 updated by: ITMO University
Selected Health and Quality of Life Indicators Among ITMO University Students, Faculty and Staff
This study assess various indicators of physical and mental health, quality of life, well-being and satisfaction among students, faculty and staff of ITMO University.
Participants are invited to join the study via informational web-site.
Several quality of life indicators are obtained via surveys and some blood samples are taken to assess health condition.
Study Overview
Status
Completed
Conditions
Detailed Description
Students, faculty and staff from ITMO University are invited to participate in health examination on the campus.
Surveys, such as EQ-5D-5L, K10+OHQ29, PSQI and others, assess different aspects of quality of life related to health.
Also participants are asked to undergo several measurements by the interviewer (waist, hips, height, weight and others).
Moreover blood samples are taken from the participants and lipidogram, cholesterol and glycohemoglobin are checked.
Study Type
Observational
Enrollment (Actual)
830
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Saint Petersburg, Russian Federation
- ITMO University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Students, faculty and staff from ITMO University
Description
Inclusion Criteria:
- student, faculty or staff from ITMO University
- participants, who signed informed consent and consent for data gathering
- participants, who signed consent to enroll in following surveys and health check-ups
Exclusion Criteria:
- participants younger than 16 years old
- participants with acute conditions distorting quality of life assessment
- participants, who did not sign informed consent and consent for data gathering - participants, who did not sign consent to enroll in following surveys and health check-ups
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
|---|
|
Healthy adults (16+)
Healthy students, faculty and staff of ITMO University older than 16 years
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Cholesterol
Time Frame: 30 days
|
Measured by A15 biochemical automatic analyzer (Biosystem, Spain)
|
30 days
|
|
Lipidogram
Time Frame: 30 days
|
Measured by A15 biochemical automatic analyzer (Biosystem, Spain)
|
30 days
|
|
Glycohemoglobin
Time Frame: 30 days
|
Measured by Architect c8000
|
30 days
|
|
Distress
Time Frame: 30 days
|
Global measure of distress based on questions about anxiety and depressive symptoms that a person has experienced in the most recent 4 week period measured by Kessler-10 questionnaire
|
30 days
|
|
Psychological well-being
Time Frame: 30 days
|
Measured by Oxford Happiness Questionnaire (OHQ)
|
30 days
|
|
Health status and quality of life
Time Frame: 30 days
|
Measured by EuroQOL-5 Dimension Questionnaire (EQ-5D-5L)
|
30 days
|
|
Nicotine dependence
Time Frame: 30 days
|
Nicotine dependence across all nicotine product types including cigarettes and electronic cigarettes measured by The Penn State Nicotine Dependence Index
|
30 days
|
|
Diabetes risk score
Time Frame: 30 days
|
The 10-year risk of type 2 diabetes mellitus (DM), including asymptomatic diabetes mellitus and impaired glucose tolerance (IGT) measured by The Finnish Diabetes Risk Score
|
30 days
|
|
Sleep quality and disturbances.
Time Frame: 30 days
|
Measured by Pittsburgh Sleep Quality Index
|
30 days
|
|
Physical activity
Time Frame: 30 days
|
The types of intensity of physical activity and sitting time that people do as part of their daily lives measured by International Physical Activity Questionnaire - Short Form
|
30 days
|
|
Emotional eating, external eating, and restrained eating behavior
Time Frame: 30 days
|
Qualitative and quantitative assessment of eating disorders associated with overeating and accompanying obesity measured by Dutch Eating Behavior Questionnaire
|
30 days
|
|
Alcohol use
Time Frame: 30 days
|
Problematic alcohol use, including possible alcohol use disorders measured by The Russian version of the Alcohol Use Disorders Identification Test (AUDIT)
|
30 days
|
|
Ischemic heart disease prediction
Time Frame: 30 days
|
Measured by The Rose angina screening questionnaire
|
30 days
|
|
Retinopathy
Time Frame: 30 days
|
Measured with non-mydriatic fundus camera
|
30 days
|
|
Ocular fundus condition
Time Frame: 30 days
|
Measured with non-mydriatic fundus camera
|
30 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 2, 2022
Primary Completion (Actual)
March 31, 2023
Study Completion (Actual)
December 31, 2023
Study Registration Dates
First Submitted
May 24, 2022
First Submitted That Met QC Criteria
May 24, 2022
First Posted (Actual)
May 27, 2022
Study Record Updates
Last Update Posted (Estimated)
March 5, 2024
Last Update Submitted That Met QC Criteria
March 4, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- 922022/4.3.1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Quality of Life
-
Ziekenhuis Oost-LimburgRecruitingQuality of Life | Postoperative Quality of Recovery | Health-Related Quality-of-LifeBelgium
-
B. Braun Medical SAUnknownQuality of Life of Colostomized Patient
-
Assiut UniversityUnknownImproving Quality of LifeEgypt
-
Istituto Ortopedico RizzoliUniversity of BolognaCompletedImprove Quality of LifeItaly
-
Children's National Research InstituteCompletedProfessional Quality of LifeUnited States
-
Mattu UniversityCompletedBreif Description: Patients' Quality of Life ofEthiopia
-
Region VästmanlandUnknownHealth Related Quality of Life
-
Ain Shams UniversityCompletedHealth Related Quality of LifeEgypt
-
Institute of Oncology LjubljanaUnknownHealth-related Quality of LifeSlovenia
-
Oslo University HospitalNorwegian Fund for Postgraduate Training in PhysiotherapyCompletedHealth-Related Quality of LifeNorway